Gencure, a subsidiary of BioBridge Global, offers a variety of ways for you to stay connected with us. You can read our latest industry new here. Or, for the social media enthusiast, the BioBridge family is known as “Connect for Life,” and can be found on Facebook, Twitter, LinkedIn and YouTube.


BioBridge Global Announces Formation Of Regenerative Medicine Advisory Board

BioBridge Global today announced the formation of a new Regenerative Medicine Advisory Board, composed of industry leaders with a wide range of scientific, product development and business experience, to support the organization’s continued growth in regenerative medicine.   BioBridge Global provides a wide range of blood, tissue and cellular source materials, products and services through […]

Read More

How GenCure is Bridging the Gap

Mike Fiske, GenCure vice president, cell manufacturing, talked about the GenCure BioManufacturing Center at a recent meeting of The Blood & Tissue Center Foundation. Fiske, whose primary goal in his first year with GenCure was getting the center up and running, explained the multiple ways the center will assist researchers in developing new therapies using […]

Read More

GenCure Opens BioManufacturing Center for Large-Scale Production of Adult Stem Cells to Support Development of New Cellular Therapies

GenCure, a subsidiary of BioBridge Global, today opened the first phase of a new biomanufacturing center designed to address a critical roadblock slowing the advancement of cellular therapies and the field of regenerative medicine: A lack of access to large-scale stem cell manufacturing and support services required for cGMP (Current Good Manufacturing Process)-compliant production of […]

Read More
blog image


GenCure is excited to announce the opening of our brand new biomanufacturing center. Our core resources have expanded to include in-house expertise in stem cell cGMP manufacturing, quality management, compliance, and testing, with the goal of developing new approaches for cell expansion and manufacturing.

Read More